Heart Attack Diagnostics Market Report 2024 (Global Edition)

Factors Affecting the Heart Attack Diagnostics Market

The unhealthy lifestyles among people are raising heart attacks and related diseases.

The common sedentary lifestyle and poor nutrition are the main causes of heart attacks. It is revealed that youths who lead modern lifestyles are more likely to suffer from heart attacks. Poor food choices like fast food, processed foods, and sugary drinks are all increasing the risk of obesity, cholesterol, and other cardiovascular diseases. Researchers have revealed that being overweight or obese increases a person’s risk of coronary heart disease by up to 28%. 
(Source: https://www.imperial.ac.uk/news/181111/fat-increased-risk-heart-disease/#:~:text=Researchers%20have%20found%20that%20being,blood%20sugar%20and%20cholesterol%20levels.) 

A lack of physical activity, loss of body workout, high tobacco consumption and smoking, high-stress levels, and inadequate healthcare can also lead to an increased risk of such disease.
For instance, a new brief by World Health Organizations, the World Heart Federation, and the University of Newcastle Australia revealed that every year, nearly 1.9 million die from tobacco-induced heart disease. 
(Source:https://www.who.int/news/item/22-09-2020-tobacco-responsible-for-20-of-deaths-from-coronary-heart-disease#:~:text=Every%20year%2C%201.9%20million%20people,Day%2C%20marked%20on%2029%20September.) 

This increased prevalence of heart-related cases is pushing people to consult healthcare services leading to the market growth of heart attack diagnostics. 

The skill shortage in healthcare services can restrict the growth of the market.

Healthcare organizations face numerous challenges in the recruiting process compared to other industries. The process of attracting and selecting candidates with specific clinical, medical, and administrative skills is crucial and an ongoing battle, especially for positions like physicians, nurses, and specialist practitioners. 

Furthermore, the rising portion of the healthcare workforce attaining retirement age, an older population seeking more healthcare services, and new technology shifting, altogether are leading to the shortage of skilled professions along with the rise in the need and demand for the same. The situation got worse when the global pandemic hit and stretched resources to the breaking point creating immense challenges for the service providers. 

The Bureau of Labor Statistics (BLS) estimates that the U.S. will face a shortage of 195,400 nurses by 2031.
The various reasons from people able to live longer to the unhealthy lifestyles of people leading to the rise in chronic disease, are increasing the need for medical professionals; however, the talent supply is unable to keep up with the demand limiting the growth of the market. 
(Source: https://www.peoplescout.com/insights/managing-skills-shortage-health-care/) 

The increasing Research & Development projects to develop digital technology for improving heart health. 

The need for technology-based solutions to enhance heart health is evident yet many people are still hesitant to accept and embrace these solutions due to issues like trust concerns, relevance, and ease of use. This gap creates an opportunity for the research community to present, validate, and create scalable, and engaging health-tech solutions to pursue them. To make it possible, various healthcare service providers, key players, and the government are continuously getting involved in investments and research to find ways to improve the facilities related to heart attack diagnostics. 

For instance, a special issue of the Journal of the American Heart Association highlights the progress of ongoing projects aimed at developing digital technology solutions to improve heart health on a global scale. The projects were funded in 2020 by more than $14 million in scientific grants through the American Heart Association’s Strategically Focused Health Technologies and Innovation Research Network. This project aimed to enhance the understanding of the ability of digital technology to improve health metrics and lower healthcare costs by engaging patients in self-care and self-prevention.
The issue highlighted some of the research works which included:
•    Deployment of Point-of-care Echocardiography to Improve Cardiac Diagnostic Access among American Indians.
•    Utilizing AI for Rheumatic Heart Disease Detection by Echocardiography

Furthermore, the American Heart Association has already invested more than $263 million to set a total of 15 Strategically Focused Research Networks.
(Source: https://www.news-medical.net/news/20240116/Research-projects-aim-to-develop-breakthrough-digital-technology-for-improving-heart-and-brain-health.aspx)

How did the COVID–19 Impact the Heart Attack Diagnostics Market?

The coronavirus disease 2019 pandemic has adversely affected the diagnosis and treatment of non-communicable diseases. It has impacted the delivery of diagnostic care for cardiovascular disease, which remained the leading cause of death worldwide. The pandemic has severely disrupted the delivery of healthcare and the lives of patients globally. Delays in the delivery of these essential services have affected health outcomes. 

For instance, the global cardiac diagnostic procedure volumes decreased by 42% from March 2019 to March 2020 and by 64% from March 2019 to April 2020. 
(Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836433/#:~:text=COVID%2D19%20was%20associated%20with,in%20care%20delivery%20is%20warranted.) 

Before COVID-19, declines in heart disease mortality had been reported in many regions of the world; however, the rates rose significantly during the first year of the COVID-19 pandemic. The COVID-19 pandemic disrupted many aspects of daily life, including access to preventive healthcare, which led to delays in detecting and treating heart-related diseases. A survey was conducted to analyze the death certificate data after occurrence of the COVID-19 revealed that the heart disease rate in the U.S. which showed a declining rate of 9.8% in 2019, rose by 4.1% in 2020. This explains the death rates which were decreasing before the pandemic, again started increasing because of the coronavirus infections.
(Source: https://www.heart.org/en/news/2022/11/03/covid-19-pandemic-erased-decade-of-progress-in-lowering-heart-disease-death-rate) 

Thus, COVID-19 affected the cardiovascular procedures volumes and abrupt reduction in diagnostic procedures across the world and these decreases and the unavailability of telehealth facilities were mostly notable in lower-income countries. 

Recent Developments

•    3rd April 2024: GE HealthCare announced the launch of Caption AI artificial intelligence (AI)-driven software for rapid cardiac assessments at the point of care on Vscan Air SL.
(Source:https://www.gehealthcare.com/about/newsroom/press-releases/ge-healthcare-introduces-caption-ai-on-vscan-air-sl-wireless-handheld-ultrasound-system-to-help-more-clinicians-capture-diagnostic-quality-cardiac-images) 
•    25th January 2024: Agepha Pharma, a leading multinational pharmaceutical company with the first FDA-approved anti-inflammatory cardiovascular treatment, together with Caristo Diagnostics, a leading cardiac disease diagnostic company with the novel CaRi-Heart technology to visualize and quantify coronary inflammation, announced their collaboration to improve awareness and clinical education about the central role of inflammation in coronary artery disease.
(Source:https://www.dicardiology.com/content/agepha-pharma-and-caristo-diagnostics-team-fight-coronary-inflammation) 
•    9th January 2024: Cleerly, the company working to create a new standard of care for the diagnosis of heart disease, announced the launch of Cleerly ISCHEMIA, after being approved by the U.S. Food and Drug Administration (FDA). Cleerly ISCHEMIA is an automated machine learning-based decision support tool, intended as a diagnostic aid for patients undergoing coronary computed tomography.
(Source:https://cleerlyhealth.com/press/cleerly-launches-ischemia-heart-disease-analysis) 
•    28th Feb 2023: Cardio Diagnostics Holdings, a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise, announced the launch of PrecisionCHD, an integrated epigenetic blood test for the early detection of coronary heart disease.
(Source:https://www.labpulse.com/business-insights/trends-and-finance/product-launch/article/15307442/cardio-diagnostics-launches-aibased-blood-test-for-the-early-detection-of-coronary-heart-disease) 
•    April 2021: The EU has granted regulatory approval to an AI-based system CaRi-Heart that can detect whether a person is at high risk of developing heart disease. 
(Source:https://aibusiness.com/verticals/ai-system-to-detect-early-signs-of-heart-disease-given-eu-regulatory-greenlight) 

With the help of the above study about the Heart Attack Diagnostics Market, it can be concluded that the market for Heart Attack Diagnostics worldwide is expected to develop significantly shortly. From the report, one can understand and infer the market dynamics, segmentations, status and trends, and key players in the market. It provides data regarding various topics such as market dimensions, prevailing trends, competitive landscape, and the outlook for prospective expansion. This allows the reader to understand and access reliable data about the market and industry.

Frequently Asked Questions (FAQs)